References
1. Karthi S, Sabarinath PS, Geetha M, Appukuttan PS. Anti-α-galactoside
and anti-β-glucoside antibodies are partially occupied by either of two
albumin-bound O-glycoproteins and circulate as ligand-binding triplets.
Immunol Invest 2019; 48 :222-241.
DOI:10.1080/08820139.2018.1502299.
2. Sandrin MS, Vaughan HA, Xing PX, McKenzie IF. Natural human anti-Gal
alpha (1,3) Gal antibodies react with human mucin peptides. Glycoconj J
1997;14 : 97–105.
3. Karthi S, Sumitha KC, Geetha M , Appukuttan PS. Amyloid β binds to
albumin-associated LRP-like plasma O-glycoproteins: albumin prevents
inhibition of binding by LDL. Protein and Peptide Letters 2019;26 :869-878. DOI: 10.2174/0929866526666190722151027
4.Wang Y, Jobe SM, Ding X, Choo H, Archer DR, Mi R, Ju T, Cummings RD.
Platelet biogenesis and functions require correct protein
O-glycosylation. Proc. Natl. Acad. Sci U S A 2012;109:16143–16148.
5. George JN. Platelet IgG: measurement, interpretation, and clinical
significance. Prog Hemost Thromb 1991;10 : 97–126.
6. Chen M, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the
primary source of amyloid β-peptide in human blood. Biochem Biophys Res
Commun 1995;213 :96–103.
7. Suresh Kumar G, Appukuttan PS, Basu D. α-D-galactose-specific lectin
from jack fruit (Artocarpus integra ) seed. J Biosci 1982;4 : 257–261.
8. Baues RJ, Grays GR. Lectin purification on affinity columns
containing reductively aminated disaccharides. J Biol Chem 1977;252 :57–60.
9.Paul A, Antony M, Mathai J, Appukuttan PS. High polymeric IgA content
facilitates recognition of microbial polysaccharide-natural serum
antibody immune complexes by immobilized human galectin-1. Immunol Lett
2011;136 : 55–60.
10.Jaison PL, Appukuttan PS. Rapid isolation of human plasma
anti-alpha-galactoside antibody using sugar-specific binding to guar
galactomannan or agarose. Indian J Biochem Biophys
1992;29 : 266–70.
11. Geetha M, Annamma KI, Mathai J, Appukuttan PS. Normal human plasma
anti-β-glucoside antibody has markedly elevated IgA content and binds
fungal and yeast polysaccharides. Immunol Invest 2007;36 :
73–83.
12.Hudson L, Hay FC. Practical immunology, 2nd ed.
Oxford:Blackwell Scientific Publications, 1980, pp. 222.
13.Jennings LK, Phillips DR. Purification of glycoproteins IIb and III
from human platelet plasma membranes and characterization of a
calcium-dependent glycoprotein IIb-III complex. J Biol Chem
1982;257 : 10458–10466.
14.Laemmli UK. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 1970;227 : 680–685.
15.Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins
from polyacrylamide gels to nitrocellulose sheets: procedure and some
applications. Proc Natl Acad Sci U S A 1979;76 : 4350–4.
16.Sastry MV, Banarjee P, Patanjali SR, Swamy MJ, Swarnalatha GV,
Surolia A. Analysis of saccharide binding to Artocarpus integrifolia
lectin reveals specific recognition of T-antigen
(beta-D-Gal(1→3)D-GalNAc). J Biol Chem 1986; 261 :11726–33.
17.Dolbeare FA. Platelet Aggregation as a Quantitative Immunologic
Technique. Immunol Commun 1973; 38 :
65-76.doi.org/10.3109/08820137309022882
18. Kelton JG, Steeves K. The amount of platelet-bound albumin parallels
the amount of IgG on washed platelets from patients with immune
thrombocytopenia. Blood 1983; 62 :924–927.
19. Galili U, Shohet SB,Kobrin E, Stults CL, Macher BA. Man, apes, and
old world monkeys differ from other mammals in the expression of
α-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263:17755–62.
20.Geetha M, Kalaivani V, Sabarinath PS, Appukuttan PS. Plasma
anti-α-galactoside antibody binds to serine- and threonine-rich peptide
sequence of apo(a) subunit in Lp(a). Glycoconj J 2014; 31 :
289–298.
21.Coller BS, Shattil SJ. The GpIIb/IIIa (integrin alpha IIb/beta3)
odyssey: a technology-driven saga of a receptor with twists, turns, and
even a bend. Blood 2008;112 :3011–25.
22.Jung SM, Yoshida N, Aoki N, Tanoue K, Yamazaki H, Moroi M.
Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of
different molecular weight. Blood 1988; 71 :915–22.
23.Rivas GA, Aznárez JA, Usobiaga P, Saiz JL, González-Rodríguez J.
Molecular characterization of the human platelet integrin GPIIb/IIIa and
its constituent glycoproteins. Eur Biophys J 1991;19 :335–45.
24.Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in
platelet activation. J Clin Invest 2004;113 :340–345.
25.Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ.
Amyloid β-peptide is transported on lipoproteins and albumin in human
plasma. J Biol Chem 1996;271 : 32916–22.
doi:10.1074/jbc.271.51.32916.
26.Donner L, Falker K, Gremer L, Klinker S, Pagani G, Ljungberg LU,
Lothmann K, Rizzi F et al. Platelets contribute to
amyloid-β aggregation in cerebral vessels through integrin
αIIb β3-induced outside-in signalling and clusterin release. Sci Signal
2016;9 : ra52.
27.Totani L, Evangelista V. Platelet-leukocyte interactions in
cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol
2010;30 : 2357–61.
28.Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl D.
Platelet-leukocyte interaction and platelet activation in acute stroke
with and without preceding infection. Arterioscler Thromb Vasc Biol
2005;25 : 1519–1523.
29.Randriamboavonjy V. Mechanisms involved in diabetes-associated
platelet hyperactivation, The non-thrombotic role of platelets in health
and disease. 2015.doi: 10.5772/60539.
30.Shechter M, Merz CN, Paul-Labrador MJ, Kaul S. Blood glucose and
platelet-dependent thrombosis in patients with coronary artery disease.
J Am Coll Cardiol 2000;35 :300–7.
31.Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein
I b, results from a variable number of tandem repeats of a 13-amino acid
sequence in the mucin-like macroglycopeptide region: structure/ function
implications. J Biol Chem 1992;26 : 10055–10061.
32.Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan BE.
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding
to human platelets. Blood 1996;88 : 907–14.
33.Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB. Diabetes
mellitus and Alzheimer’s disease: shared pathology and treatment? Brit J
Clin Pharm 2011;71 : 365-76.
34.Zheng F, Yan L, Yang
Z, Zhong
B, Xie
W. HbA1c, diabetes and cognitive decline: the English
Longitudinal Study of Ageing. Diabetologia 2018;61 :839–848.
35.Sevush S, JY W, Horstman LL, Mao WW, Kolodny L, Abn YS. Platelet
activation in Alzheimer disease. Arch. Neurol 1998; 55 :
530–6.
36.Gresele P, Guglielmini G, De Angelis M, Cifferi S, Ciofetta M,
Falcinelli E,Lalli C, Ciabattoni G et al . Acute, short-term
hyperglycemia enhances shear stress-induced platelet activation in
patients with type II diabetes mellitus. J Am Coll Cardiol 2003;41 : 1013–20.
37.Neumann F-J, Zohlnhöfer D, Fakhoury L, Ott I, Gawaz M, Schomig A.
Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte
interaction and surface expression of the leukocyte integrin Mac-1 in
acute myocardial infarction. J Am Coll Cardiol 1999;34 :1420-1426. DOI: 10.1016/S0735-1097(99)00350-2